EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Extracellular vesicles ( EVs ): A promising therapeutic tool in the heart tissue regeneration

Francesca Diomede, Simone Guarnieri, Paola Lanuti, Fani Konstantinidou, Valentina Gatta, Thangavelu Soundara Rajan, Sante D Pierdomenico, Oriana Trubiani iD, Guya Diletta Marconi iD, Jacopo Pizzicannella

BioFactors · 2024

DOI: 10.1002/biof.2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioFactors, 2024. Verfasst von Francesca Diomede und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Innovative Technologies in Medicine & Dentistry, University "G. d'Annunzio" Chieti-Pescara, Chieti, Italy. Hauptthemen laut MEDLINE: Extracellular Vesicles, Cell Differentiation, Myocytes, Cardiac, MicroRNAs. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Union-NextGenerationEU, Italian Ministry of University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mesenchymal stem cells (MSCs) treatment has been widely explored as a therapy for myocardial infarction, peripheral ischemic vascular diseases, dilated cardiomyopathy, and pulmonary hypertension. Latest in vitro studies suggest that MSCs can differentiate into contractile cardiomyocytes. One of the best‐characterized MSCs products are MSCs‐derived extracellular vesicles (EVs). EVs are crucial paracrine effectors of MSCs. Based on previous works, paracrine effects of MSCs play a primary role in the regenerative ability. Hence, in the current paper, we focused our attention on an alternative approach, exploiting products derived from human dental pulp stem cells (hDPSCs) rather than MSCs themselves, which may denote a cost‐effective and safer approach. The focus has been on EVs and the bioactive molecules they contain to evaluate their ability to influence the differentiation process toward cardiomyogenic lineage. The expression of GATA4, ACTC1, CX43, and Nkx2.5 was evaluated using Immunofluorescence, real time‐PCR, and Western blotting analyses. Furthermore, the expression profiling analysis of the microRNA hsa‐miR‐200c‐3p, targeting the GATA4 gene, was studied. The hsa‐miR‐200c‐3p was found significantly down‐regulated in both c‐hDPSCs + EVs‐hDPSCs and c‐hDPSCs + EVs‐HL‐1 compared to untreated c‐hDPSCs underlying a possible epigenetic mechanism behind the prevalent up‐regulation of its targeted GATA4 gene. The aim of the present work was to develop an in vitro model of hDPSCs able to differentiate into cardiomyocytes in order to investigate the role of EVs derived from hDPSCs and derived from HL‐1 cardiomyocyte cell line in modulating the differentiation process toward cardiomyogenic lineage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesCell DifferentiationMyocytes, CardiacMicroRNAsMesenchymal Stem CellsDental PulpRegenerationHumansHomeobox Protein Nkx-2.5GATA4 Transcription FactorConnexin 43Cells, Cultured

Stichwörter der Autor:innen

cardiomyocytedental pulp stem cellsextracellular vesiclesoral mesenchymal stem cells

Substanzen

MicroRNAsHomeobox Protein Nkx-2.5GATA4 Transcription FactorConnexin 43NKX2-5 protein, humanGATA4 protein, human

Autor:innen und Institutionen

  • Department of Innovative Technologies in Medicine & Dentistry, University "G. d'Annunzio" Chieti-Pescara, Chieti, Italy.
  • Department of Neuroscience, Imaging and Clinical Sciences, Center for Advanced Studies and Technology (CAST), University "G. d'Annunzio" Chieti-Pescara, Chieti, Italy.
  • Department of Medicine and Aging Sciences, Center for Advanced Studies and Technology (CAST), University "G. d'Annunzio" Chieti-Pescara, Chieti, Italy.
  • Department of Psychological Health and Territorial Sciences, School of Medicine and Health Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
  • Unit of Molecular Genetics, Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
  • Research and Development Unit, Theertha Biopharma Private limited, KIADB, Industrial Area, Bangalore, India.

ORCID-Profile: Oriana Trubiani, Guya Diletta Marconi

Förderung

  • European Union-NextGenerationEU
  • Italian Ministry of University

Zitieren

APA

Diomede, F., Guarnieri, S., Lanuti, P., Konstantinidou, F., Gatta, V., Rajan, T. S., Pierdomenico, S. D., Trubiani, O., Marconi, G. D., & Pizzicannella, J. (2024). Extracellular vesicles ( EVs ): A promising therapeutic tool in the heart tissue regeneration. BioFactors. https://doi.org/10.1002/biof.2025

Vancouver

Diomede F, Guarnieri S, Lanuti P, Konstantinidou F, Gatta V, Rajan TS, et al. Extracellular vesicles ( EVs ): A promising therapeutic tool in the heart tissue regeneration. BioFactors. 2024. doi:10.1002/biof.2025

BibTeX
@article{Diomede2024,
  author = {Diomede, Francesca and Guarnieri, Simone and Lanuti, Paola and Konstantinidou, Fani and Gatta, Valentina and Rajan, Thangavelu Soundara and Pierdomenico, Sante D and Trubiani, Oriana and Marconi, Guya Diletta and Pizzicannella, Jacopo},
  title = {Extracellular vesicles ( EVs ): A promising therapeutic tool in the heart tissue regeneration},
  journal = {BioFactors},
  year = {2024},
  doi = {10.1002/biof.2025}
}
Kostenlos starten →